The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity
Diseases characterized by abnormal low and high body weight are common in the community and
 are associated with significant morbidity, mortality and health care related costs.

 Genetic, dietary, social and psychologic factors all play an important part in these
 conditions; however the central role of gastrointestinal (GI) function and the control of
 nutrient delivery to the small bowel has not been well described in health or disease.

 We propose that the GI response to feeding varies inversely with body weight. This hypothesis
 predicts that as body weight increases, the response to a given meal decreases in terms of
 motility, neurohormonal feedback, sensation and satiety. This provides an attractive
 explanation for why thin individuals stop eating after a small amount of food (i.e. limited
 gastric relaxation, rapid gastric emptying, powerful nutrient feedback with early
 satiety)and, conversely, why obese patients continue to eat even after nutritional
 requirements have been met (i.e. large gastric relaxation, slow gastric emptying, weak
 nutrient feedback with delayed satiety).

 This project will apply MRI and Breath Tests to assess GI motility, hormonal feedback,
 visceral sensation and satiety in patients with pathologically low (anorexia nervosa) and
 high (morbid obesity) body weight and in healthy, normal weight controls.

 Participants will include: Group A: normal weight, healthy volunteers (n=24: BMI: 18.5-24.9
 kg/m2) Group B: patients with anorexia nervosa (DSMIV criteria and BMI: <16 kg/m2) B1:
 anorexia restricting type (n=12-20 over 2 years) and B2: anorexia bulimia type (n=20 over 2
 years) Group C: patients with morbid obesity (BMI: 30-40 kg/m2) C1: obese (n=20 over 2 years)
 and C2: obese with DM type II (n=20 over 2 years).

 Two studies will be performed

 1. Cross-sectional study: The effects of a test meal on GI motility, hormonal feedback,
 visceral sensation and satiety in healthy controls and in patients with anorexia and
 obesity

 2. Longitudinal study: The effects of dietary treatment (i.e. weight change) on GI
 motility, hormonal feedback, visceral sensation and satiety in patients with anorexia
 and obesity
In addition to satisfying specific DSMIV criteria for anorexia nervosa (B1, B2) or WHO
 criteria for obesity (C1), or obesity and diabetes mellitus type II (C2), general inclusion
 criteria include:

 -  aged at least 18 and not more than 40 years

 -  able to communicate well with the investigators and provide written consent

 -  no physical co-morbidity requiring active treatment, in particular diabetes mellitus,
 impairment of liver or kidney function (subjects with diabetes mellitus type II are
 eligible for study group C2)

 -  no psychiatric (DSM IV) disorders limiting the ability to comply with study
 requirements

 -  no use of medications influencing upper GI motility within one week of the study (i.e.
 nitrates, prokinetic drugs, macrolide antibiotics). Acid suppression and
 antihypertensive medication beta-blocker, calcium channel blockers are acceptable.

 -  no evidence of current drug or alcohol abuse

 -  no history of gastrointestinal disease or surgery except appendicectomy or hernia
 repair

 -  females will take a urine pregnancy test before each study, any participant with a
 positive pregnancy test will be excluded (females will be investigated always in the
 same menstrual phase)

 Exclusion criteria:

 • pregnancy